Literature DB >> 10022110

Sexual dysfunction in the United States: prevalence and predictors.

E O Laumann1, A Paik, R C Rosen.   

Abstract

CONTEXT: While recent pharmacological advances have generated increased public interest and demand for clinical services regarding erectile dysfunction, epidemiologic data on sexual dysfunction are relatively scant for both women and men.
OBJECTIVE: To assess the prevalence and risk of experiencing sexual dysfunction across various social groups and examine the determinants and health consequences of these disorders.
DESIGN: Analysis of data from the National Health and Social Life Survey, a probability sample study of sexual behavior in a demographically representative, 1992 cohort of US adults. PARTICIPANTS: A national probability sample of 1749 women and 1410 men aged 18 to 59 years at the time of the survey. MAIN OUTCOME MEASURES: Risk of experiencing sexual dysfunction as well as negative concomitant outcomes.
RESULTS: Sexual dysfunction is more prevalent for women (43%) than men (31%) and is associated with various demographic characteristics, including age and educational attainment. Women of different racial groups demonstrate different patterns of sexual dysfunction. Differences among men are not as marked but generally consistent with women. Experience of sexual dysfunction is more likely among women and men with poor physical and emotional health. Moreover, sexual dysfunction is highly associated with negative experiences in sexual relationships and overall well-being.
CONCLUSIONS: The results indicate that sexual dysfunction is an important public health concern, and emotional problems likely contribute to the experience of these problems.

Entities:  

Mesh:

Year:  1999        PMID: 10022110     DOI: 10.1001/jama.281.6.537

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  677 in total

Review 1.  Recent advances in female sexual dysfunction.

Authors:  A R Davis
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

2.  Viagra and broken hearts.

Authors:  S Holzapfel
Journal:  Can Fam Physician       Date:  2000-02       Impact factor: 3.275

Review 3.  Female low sexual desire and sexually transmitted infections.

Authors:  D Goldmeier
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

Review 4.  Neurogenic female sexual dysfunction: a review.

Authors:  M L Sipski; A Behnegar
Journal:  Clin Auton Res       Date:  2001-10       Impact factor: 4.435

5.  Sexual behaviour and its medicalisation: in sickness and in health.

Authors:  Graham Hart; Kaye Wellings
Journal:  BMJ       Date:  2002-04-13

6.  Transdermal testosterone replacement to improve women's sexual functioning.

Authors:  K D Louie
Journal:  Can Fam Physician       Date:  2001-08       Impact factor: 3.275

7.  Measurement of male and female sexual dysfunction.

Authors:  R C Rosen
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

Review 8.  Prevalence of and recent developments in female sexual dysfunction.

Authors:  R Shabsigh
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

9.  Evaluation of sexual function in women at two stages of multiple sclerosis.

Authors:  Fatih Firdolas; Tunc Ozan; Rahmi Onur; Serpil Bulut; Irfan Orhan
Journal:  World J Urol       Date:  2012-06-06       Impact factor: 4.226

Review 10.  Sexual dysfunction and depression.

Authors:  S N Seidman; S P Roose
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.